An interventional study of intravenous & intramuscular oxytocin and after delivery of the fetus & when anterior shoulder seen in Postpartum Bleeding, sponsored by Etlik Zubeyde Hanim Womens' Health and Teaching Hospital. Completed at 1 site in Turkey. Open to female participants. Per ClinicalTrials.gov, last updated 2013-10-01.
Sponsored by Etlik Zubeyde Hanim Womens' Health and Teaching Hospital · Not applicable and Interventional
To compare the efficacy of the route and timing of oxytocin administration for Active management of third stage of labour (AMTSL).
Our objective is to determine the most efficient route and timing of oxytocin administration by measuring the duration of third stage of labour, quantitative blood during the first hour after delivery and comparing haemoglobin and haematocrit changes and the need for additional interventions in patients who had either a spontaneous labour or received labour augmentation with oxytocin.
445 studies on the registry are indexed under Postpartum Hemorrhage; 75 are open to participants now.
This study's enrollment of 600 is above the median of 148 across 340 interventional studies indexed under Postpartum Hemorrhage.
Browse Postpartum Hemorrhage studies →Etlik Zubeyde Hanim Womens' Health and Teaching Hospital is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
intravenous or intramuscular 10 iu oxytocin
Procedure: after delivery of the fetus & when anterior shoulder seen
oxytocin 10 iu after the delivery of the fetus or when the anterior shoulder was seen after the fetal head was delivered
Drug: intravenous & intramuscular oxytocin
intravenous or intramuscular 10 iu oxytocin
Also known as: Postuitrin
oxytocin 10 iu after the delivery of the fetus or when the anterior shoulder was seen after the fetal head was delivered
postpartum bleeding in the third stage of labour
Time frame: participants will be followed for the duration of hospital stay, an expected average of 48 hours
This study is completed, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Etlik Zubeyde Hanim Womens' Health and Teaching Hospital